GRANT SPONSORS: COVID-19 NOTICES AND UPDATES
SPA is actively receiving and seeking out current updates from our grant sponsors regarding grant activities affected by the COVID-19 pandemic. The information below will be updated throughout the day as new information is received.
Contact your SPA grant specialist, Carmen Martinez, or Kathleen Kreider with any questions you may have.
SPA工作人员正在校园内与骨骼工作人员进行远程合作。
Office of Management and Budget：has authorized federal granting agencies the flexibility in several administrative areas of due to loss of operational capacity and increased costs due to COVID-19.https://www.whitehouse.gov/wp-content/uploads/2020/03/m-20-17.pdf
Cogr矩阵：联邦机构行政灵活性
Each federal agency will release it’s own implementation plan.
NIH:YouTube message from Mike Lauer, M.D. regarding administrative grant flexibilities
NIHWebsite updates and FAQs:https://grants.nih.gov/grants/natural_disasters/corona-virus.htm
NIH提案提交：https://grants.nih.gov/grants/guide/notice-files/not-od-20-082.html
NIHAward Management/Reporting:https://grants.nih.gov/grants/guide/notice-files/not-od-20-086.html
CPRIT：Covid-19 webpage为受赠人和申请人。https://www.cprit.texas.gov/about-us/novel-coronavirus-covid-19
DHHS-儿童和家庭的管理（ACF）：Released grant flexibilities statement.Read here
Howard Hughes Medical Institute suspends Medically Trained Scientists Programhttps://www.hhmi.org/news/hhmi-opens-new-program-for-medically-trained-scientists
南德克萨斯州卫理公会医疗部：Read Here
NSF:https://www.nsf.gov/bfa/dias/policy/covid19/covid19faqs_propoposerandawardee.pdf
SAMHSA：https://www.samhsa.gov/coronavirus/discretionary-grant-recipients
TDSHS：Options for 90-day Administrative Relief:Read Here
TWCGovernor’s Summer Merit Program：Cancelled for this year:Read Here
USAMRAA:https://ebrap.org/ebrap/public/covid-19_faqs_usamraa_16_march_2020.html
Center for Clinical And Translational Sciences (CCTS) at UTHealth:Letter from David McPherson, M.D. regarding ongoing support of clinical trials.Read Here。
Subrecipients/Subawards:Sponsored Projects Officers around the country have confirmed that they are operating remotely and will continue to issue subawards as scheduled.
Proposal Deadline Extensions and Other Opportunities
Harrington Discovery Institute:Deadline extendedfor Scholar Innovator Award (MD required, all disease areas, $100,000 - $700,000)and the Scholar Award (Partner with Alzheimer’s Drug Discovery Foundation,博士或医学博士，阿尔茨海默氏症和痴呆症，其他药物开发计划，最高60万美元）https://www.uhhospitals.org/harrington-discovery-institute/funding-and-programs/alzheimers-drug-discovery-foundation-harrington-program
PCORI Phased Large Awards for Comparative Effectiveness:RFA将打开6/9/20,由于9/29/20法则,应用程序due 1/12/21. $2 million Feasibility phase and $20 million full-scale study phase for high-quality comparative effectiveness research (CER) projects that will examine a critical patient-centered research question that is also relevant to decision makers and other stakeholders. For this PFA, investigators should propose an individual-level or cluster randomized controlled trial of significant scale and scope, requiring funding in excess of $10 million in direct costs. The proposed trials should address important decisional dilemmas that require important new evidence about the comparative effectiveness of available interventions. Proposed studies should compare interventions that already have established evidence of efficacy or are in widespread use. Clinical interventions (such as medications, diagnostic tests, or procedures) and delivery system interventions are appropriate for study.https://www.pcori.org/funding-opportunities/announcement/phased-large-awards-comparative-effectiveness-research-cycle-3-2020?utm_source=placer&utm_medium=email&utm_campaign=030420
Requests for Proposals to Address COVID-19
Cornerstone - Covid-19的联邦资金机会清单
4/9/20-page 7 begins description of each opportunity by fed agency.Read Here
4/10/20 - 新机会。Read Here
NOT-AI-20-034 |
National Institute of Allergy and Infectious Diseases (NIAID） |
|
NOT-AI-20-040 |
National Institute of Allergy and Infectious Diseases (NIAID） |
|
NOT-GM-20-025 |
美国国家一般医学科学研究所（NIGMS） |
|
NOT-AI-20-030 |
有关2019年小说冠状病毒（2019-NCOV）的研究的急性竞争修订的特殊兴趣通知（NOSI）（NOSI）beplay苹果手机能用吗 |
National Institute of Allergy and Infectious Diseases (NIAID） |
NOT-HL-20-757 |
国家心脏，肺和血液研究所（NHLBI） |
|
NOT-DA-20-047 |
美国国家药物滥用研究所（NIDA） |
|
NIH：CTSA特别关注通知(2 RFAs for a supplement and limited competition under our UL1 award). If you wish to submit a proposal in response to one of these RFA’s, please contact David McPherson, MD, PI for the UTHealth CTSA.
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-011.html